Daxxify
Botulinum toxin type a · Revance Therapeutics, Inc.
PRESCRIPTION ONLY (USA)Daxxify ingredients
| Active ingredient | Strength |
|---|---|
| Botulinum Toxin Type A | 100 U/1.2mL |
What Daxxify is used for
Daxxify is a specialist medicine (acetylcholine release inhibitor, neuromuscular blocker). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Daxxify
- Generic name
- Botulinum toxin type a
- Made by
- Revance Therapeutics, Inc.
- Forms
- Injection, Powder, Lyophilized, For Solution
- Given
- Intramuscular
- Drug class
- Acetylcholine Release Inhibitor, Neuromuscular Blocker
- FDA approval
- Biologic licence (BLA) BLA761127
- On the US market since
- 2022
Official information
- Daxxify prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Botulinum toxin type a)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Daxxify?
Daxxify (Botulinum toxin type a) is a specialist medicine made by Revance Therapeutics, Inc., approved by the US FDA.
What are the ingredients of Daxxify?
Daxxify contains Botulinum Toxin Type A (100 U/1.2mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA